NeoImmuneTech, Inc. (KOSDAQ:950220)
South Korea
· Delayed Price · Currency is KRW
1,075.00
+9.00 (0.84%)
May 14, 2025, 11:40 AM KST
NeoImmuneTech Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| May '25 May 13, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 21,079 | 22,245 | 40,041 | 78,963 | 203,671 | - | |
| Market Cap Growth | -44.44% | -44.44% | -49.29% | -61.23% | - | - | |
| Enterprise Value | -2,986 | -14,035 | -37,279 | -56,272 | 42,088 | - | |
| Last Close Price | 1066.00 | 1125.00 | 2025.00 | 3995.00 | 10350.00 | - | |
| PS Ratio | 123.71 | 130.56 | - | - | - | - | |
| PB Ratio | 0.51 | 0.53 | 0.54 | 0.66 | 1.26 | - | |
| P/TBV Ratio | 0.60 | 0.63 | 0.58 | 0.70 | 1.31 | - | |
| Debt / Equity Ratio | 0.26 | 0.26 | 0.05 | 0.04 | 0.04 | 0.03 | |
| Asset Turnover | 0.00 | 0.00 | - | - | - | - | |
| Quick Ratio | 1.68 | 1.68 | 5.36 | 7.14 | 7.57 | 7.91 | |
| Current Ratio | 1.89 | 1.89 | 5.61 | 7.20 | 8.17 | 8.96 | |
| Return on Equity (ROE) | -70.17% | -70.17% | -54.90% | -42.88% | -42.62% | -30.44% | |
| Return on Assets (ROA) | -32.84% | -32.84% | -30.30% | -22.25% | -22.95% | -18.02% | |
| Return on Capital (ROIC) | -39.04% | -39.04% | -34.34% | -24.88% | -25.45% | -18.99% | |
| Earnings Yield | -193.96% | -183.78% | -133.37% | -76.50% | -25.77% | - | |
| FCF Yield | -207.64% | -196.75% | -126.25% | -56.84% | -17.97% | - | |
| Buyback Yield / Dilution | 0.22% | 0.22% | -0.06% | -3.68% | -15.27% | -1.50% | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.